IRIS
TESSITORE, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.243
EU - Europa 3.128
AS - Asia 2.645
SA - Sud America 409
Continente sconosciuto - Info sul continente non disponibili 250
AF - Africa 42
OC - Oceania 6
Totale 11.723
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.123
SG - Singapore 1.116
RU - Federazione Russa 649
CN - Cina 594
IE - Irlanda 558
IT - Italia 463
BR - Brasile 351
DE - Germania 338
SE - Svezia 293
TR - Turchia 252
VN - Vietnam 246
HK - Hong Kong 229
FR - Francia 195
GB - Regno Unito 184
UA - Ucraina 146
FI - Finlandia 133
CA - Canada 67
BD - Bangladesh 53
IN - India 45
CZ - Repubblica Ceca 40
MX - Messico 31
BE - Belgio 23
ES - Italia 23
JP - Giappone 22
PL - Polonia 22
ZA - Sudafrica 21
NL - Olanda 20
IQ - Iraq 18
AR - Argentina 15
EC - Ecuador 12
CO - Colombia 9
AT - Austria 8
KR - Corea 8
MY - Malesia 8
ID - Indonesia 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CR - Costa Rica 6
PK - Pakistan 6
AU - Australia 5
SA - Arabia Saudita 5
UY - Uruguay 5
CH - Svizzera 4
CL - Cile 4
LT - Lituania 4
PH - Filippine 4
PT - Portogallo 4
TN - Tunisia 4
UZ - Uzbekistan 4
DZ - Algeria 3
EU - Europa 3
JM - Giamaica 3
MA - Marocco 3
NP - Nepal 3
PY - Paraguay 3
RO - Romania 3
BG - Bulgaria 2
EE - Estonia 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
IR - Iran 2
JO - Giordania 2
LB - Libano 2
LY - Libia 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RS - Serbia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CD - Congo 1
CM - Camerun 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GF - Guiana Francese 1
GH - Ghana 1
GI - Gibilterra 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
JE - Jersey 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
MQ - Martinica 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
Totale 11.471
Salva come PNG Salva come JPEG
Città #
Chandler 622
Singapore 599
Dallas 586
Jacksonville 566
Dublin 553
San Jose 495
Ashburn 330
Santa Clara 234
Boardman 227
Hong Kong 226
Council Bluffs 159
Izmir 135
New York 131
The Dalles 104
Beijing 103
Moscow 101
Nanjing 98
Munich 85
Los Angeles 80
Princeton 80
San Mateo 80
Lawrence 79
Ho Chi Minh City 75
Wilmington 74
Ann Arbor 73
L'aquila 55
Lauterbourg 55
L’Aquila 54
Hanoi 46
Bremen 45
Woodbridge 43
Milan 42
Helsinki 41
São Paulo 41
Brno 39
Rome 39
Nanchang 35
Shenyang 29
Dong Ket 28
Montreal 28
Seattle 28
Brussels 23
Shanghai 23
Tianjin 22
Verona 22
Warsaw 22
Tokyo 21
Aquila 20
Columbus 20
Kitzingen 20
Houston 19
Turku 19
Brooklyn 18
Orem 18
Atlanta 17
Chicago 17
Frankfurt am Main 17
Phoenix 17
Des Moines 16
Johannesburg 16
London 16
Jiaxing 15
Mountain View 15
Casoria 14
Hebei 14
Hefei 14
Philadelphia 14
Chennai 13
Kunming 13
Lappeenranta 13
Manchester 13
Toronto 13
Zhengzhou 13
Changsha 12
Da Nang 12
Falkenstein 12
Mexico City 11
Norwalk 11
Poplar 11
San Francisco 11
Amsterdam 10
Denver 10
Pune 10
Buffalo 9
Dearborn 9
Guangzhou 9
Ningbo 9
Assago 8
Brasília 8
Haiphong 8
Jinan 8
Redwood City 8
Stockholm 8
Boston 7
Campinas 7
Lissone 7
Ninh Bình 7
Nuremberg 7
Querétaro 7
Taizhou 7
Totale 7.333
Salva come PNG Salva come JPEG
Nome #
The prevalent KRAS exon 2 c.35 G > A mutation in metastatic colorectal cancer patients: a biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens? 200
Involvement of an arachidonic-acid-dependent pathway in the interferon-beta-mediated expression of C202 gene in Ehrlich-ascites-tumor cells 187
KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease. 186
new bioinformatics approach to identify target genes for dysregulated micrornas in a chemically-induced hepatocarcinoma mouse model 184
Bioinformatics approach to predict target genes for dysregulated microRNAs in hepatocellular carcinoma: Study on a chemically-induced HCC mouse model 176
mir-182 dysregulation in a diet-induced NAFLD-NASH-hepatocellular carcinoma mouse model 173
EFFECTS OF SAFFRON ON HEPATOCARCINOGENESIS PROCESS: A STUDY ON A MOUSE MODEL 173
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations. 171
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis. 169
Therapeutic Use of MicroRNAs in Cancer 168
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma 167
Concurrent RAS and RAS/BRAF V600E variants in colorectal cancer: more frequent than expected? 162
Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach? 161
MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice 158
Next-generation sequencing: Recent applications to the analysis of colorectal cancer 158
MicroRNAs Expression in Response to rhNGF in Epithelial Corneal Cells: Focus on Neurotrophin Signaling Pathway 156
Longitudinal monitoring of mRNA levels of regulatory T cell biomarkers by using non-invasive strategies to predict outcome in renal transplantation 153
Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a nafld/nash mouse model 152
Emerging role of isomirs in cancer: State of the art and recent advances 152
MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression 151
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 150
development of hepatocellular cancer in a murine model of nonalcoholic steatohepatitis induced by use of low-fat/high carbohydrate diet 148
Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma 147
Cancer secretome and inflammation: The bright and the dark sides of NF-kB 147
ANALISI DEL miRNoma NELL’EPATOCARCINOMA INDOTTO DA DIETILNITROSAMINA 146
Low Radiation Environment Switches the Overgrowth-Induced Cell Apoptosis Toward Autophagy 145
two simulteneous and very uncommom pi3kca mutations in a liver metastasis from colorectal cancer patient with aggressive and resistant disease 144
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status. 141
Angiotensin II stimulates intercellular adhesion molecule-1(ICAM1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo 140
Circulating micrornas as prognostic and therapeutic biomarkers in breast cancer molecular subtypes 139
Serum biomarkers identification by mass spectrometry in high-mortality tumors. 138
New mutations and protein variants of NBSI are identified in cancer cell lines 137
Ultrasound-based method for the identification of novel microrna biomarkers in prostate cancer 133
Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells 131
Two gamma-interferon-activation sites (GAS) on the promoter of the human intercellular adhesion molecule 1 (ICAM-1) gene are required for induction of transcription by IFN-gamma 131
The Role of Circulating MicroRNAs as Biomarkers in NAFLD 131
the role of kctd11 tumor suppressor gene in prostate cancer 128
crosstalk between nf-kb and shh pathways in prostate cancer 127
A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: The SynapSES trial 127
Novel P53 mutations detected by FAMA in colorectal cancers 125
KCTD11 tumor suppressor gene expression is reduced in prostate adenocarcinoma 125
Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel 125
Codon optimization by 0-1 linear programming 125
MicroRNA profiling in women with migraine: effects of CGRP-targeting treatment 125
Characterization of a novel HLA-Cw*02 variant, Cw*0208, in a Caucasian individual 124
A KRAS and dual concomitant PI3KCA mutations in a metastatic colorectal cancer patient with aggressive and resistant disease 124
MIRNOME ANALYSIS IN THE PATHOGENESIS OF HEPATOCARCINOMA 123
Classification of tumor types using XGBoost machine learning model: a vector space transformation of genomic alterations 122
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 120
The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. 120
Prognostic relevance of KRAS genotype and the prevalent C.35 G > a mutation in metastatic colorectal cancer (MCRC) patients fitting for intensive FIr-B/FOx triplet chemotherapy plus bevacizumab 119
Takotsubo Syndrome during Pertuzumab and Trastuzumab Therapy for HER2-Positive Metastatic Breast Cancer 118
MicroRNAs in the DNA Damage/Repair Network and Cancer 117
Can analysis of the molecular status of the p53 gene contribute to improving the therapeutic strategy for breast carcinoma? 115
A method to comprehensively identify germline SNVs, INDELs and CNVs from whole exome sequencing data of BRCA1/2 negative breast cancer patients 111
General Direct Anticancer Effects of Deer Growing Antler Extract in Several Tumour Cell Lines, and Immune System-Mediated Effects in Xenograft Glioblastoma 111
Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery 110
Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer 110
Human leukocyte antigen-A, -B, and -Cw polymorphism in a Berber population from North Morocco using sequence-based typing 109
Neuroprotective effects of human amniotic fluid stem cells-derived secretome in an ischemia/reperfusion model 108
Ultrasound as a New Method for the Release and Identification of Novel microRNAs and Proteins as Candidate Biomarkers in Pancreatic Cancer 107
Identification of the uncommon allele HLA-A*7403 in a Caucasian renal transplant cadaveric donor: Extension of the exon 4 sequence 107
A NEW ALLELE, MICA*078, IDENTIFIED IN A MOROCCAN INDIVIDUAL WITH CELIAC DISEASE 107
Long-term abuse of a high-carbohydrate diet is as harmful as a high-fat diet for development and progression of liver injury in a mouse model of NAFLD/NASH 107
Identification of a novel HLA-DRB1*11 allele: DRB1*1152 105
Pharmacogenetics and clinical oncology: a new deal for personalized therapies 103
Prognostic value of p53 molecular status in high-risk primary breast cancer 103
MICA∗078: A novel allele identified in a moroccan individual affected by celiac disease. 102
A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal Cancer. 102
High sensitivity of detectionof TP53 somatic mutations by fluorescence-assisted mismatch analysis 102
Identification of the novel allele B*4427 and a confirmatory sequence (B*44022) 102
Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition 101
Smart hydrogel particles: Biomarker harvesting: One-step affinity purification, size exclusion, and protection against degradation 101
Identification of a novel allele variant of HLA-B*57 in a Caucasian Moroccan individual: B*57032 100
Prenatal diagnosis of a rhodopsin mutation using chemical cleavage of the mismatch 100
Role of Circulating microRNAs in Liver Disease and HCC: Focus on miR-122 99
MiRNome analysis in high-fat diet-induced hepatocarcinoma. 99
Reverse-phase protein microarray highlights HER2 signaling activation in immunohistochemistry/FISH/HER2-negative breast cancers. 98
Identification of a novel HLA-A*02 allele, A*027401* 98
Serum low-molecular-weight protein fractionation for biomarker discovery 97
Role of the Molecular Tumor Board for the Personalized Treatment of Patients with Metastatic Breast Cancer: A Focus on the State of the Art in Italy 96
Increased CD1D polymorphism: identification of two novel alleles, CD1D*03 and *04, in individuals from Morocco. 95
Analytical scanning of p53 mutations by FAMA (fluorescence assisted mismatch analysis) in colorectal cancers and preliminary prognostic findings. 94
Prognostic significance of P53 mutations in high risk node positive breast cancer patients 94
Role of bcr-abl in the regulation and inhibition of apoptosis 90
SMO-M2 mutation does not support cell-autonomous Hedgehog activity in cerebellar granule cell precursors 90
Mass spectrometry driven discovery proteomics of serum from mice with human ovarian cancer resulted in identification of a potential cancer-origin biomarker that correlates with peritoneal tumor burden. 87
An initial characterization of the serum phosphoproteome. 87
IDENTIFICATION OF TWO NOVEL ALLELES, CD1D*03 AND*04, IN INDIVIDUALS FROM MOROCCO 84
MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors 83
Efficacy and tolerability of Everolimus-Exemestane combination therapy in metastatic breast cancer patients: experience in Real Life 82
MicroRNAs expression analysis in high-fat diet induced NAFLD-NASH-HCC progression: study on C57BL/6J mice 74
Detection of NBS1 (Nibrin) mutations in breast and ovarian cancer 61
null 38
null 35
Anthracycline-Free Neoadjuvant Pertuzumab-Trastuzumab-Taxane in Patients with HER2-Positive Early Breast Cancer: Hormone Receptor Status as a Key Determinant of Pathological Complete Response 11
Effect of Osteoblast-Derived Extracellular Vesicles on Osteosarcoma Cells’ Transcriptional Profile: Role of Shuttled miRNAs 9
Totale 11.723
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.592
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.592
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022454 0 0 128 43 21 5 9 28 35 9 33 143
2022/20231.684 106 125 30 213 167 184 2 86 682 11 56 22
2023/2024474 46 26 19 41 31 118 2 45 0 18 29 99
2024/20251.993 83 62 228 103 193 158 278 188 366 68 137 129
2025/20264.180 218 387 442 544 417 305 571 108 325 569 204 90
2026/2027227 83 111 33 0 0 0 0 0 0 0 0 0
Totale 11.723